Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer.
Biomedicines. 2023 Oct 17;11(10):2812. doi: 10.3390/biomedicines11102812.
Biomedicines. 2023.
PMID: 37893184
Free PMC article.
Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells.
Valle S, Alcalá S, Martin-Hijano L, Cabezas-Sáinz P, Navarro D, Muñoz ER, Yuste L, Tiwary K, Walter K, Ruiz-Cañas L, Alonso-Nocelo M, Rubiolo JA, González-Arnay E, Heeschen C, Garcia-Bermejo L, Hermann PC, Sánchez L, Sancho P, Fernández-Moreno MÁ, Sainz B Jr.
Valle S, et al. Among authors: munoz er.
Nat Commun. 2020 Oct 16;11(1):5265. doi: 10.1038/s41467-020-18954-z.
Nat Commun. 2020.
PMID: 33067432
Free PMC article.
Item in Clipboard
Cyclooxygenase 2 Effector Genes as Potential Inflammation-Related Biomarkers for Colorectal Cancer Circulating Tumor Cells Detection by Liquid Biopsy.
Stamatakis K, Torres-Gérica P, Jiménez-Segovia A, Ramos-Muñoz E, Crespo-Toro L, Fuentes P, Toribio ML, Callejas-Hernández F, Carrato A, García Bermejo ML, Fresno M.
Stamatakis K, et al. Among authors: ramos munoz e.
Front Pharmacol. 2022 Jan 28;12:806395. doi: 10.3389/fphar.2021.806395. eCollection 2021.
Front Pharmacol. 2022.
PMID: 35153760
Free PMC article.
Item in Clipboard
Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study.
Conde E, Earl J, Crespo-Toro L, Blanco-Agudo C, Ramos-Muñoz E, Rodríguez-Serrano EM, Martínez Ávila JC, Salinas-Muñoz L, Serrano-Huertas S, Ferreiro R, Rodriguez-Garrote M, Sainz B Jr, Massuti B, Alfonso PG, Benavides M, Aranda E, García-Bermejo ML, Carrato A.
Conde E, et al. Among authors: ramos munoz e.
Cancers (Basel). 2021 Apr 4;13(7):1710. doi: 10.3390/cancers13071710.
Cancers (Basel). 2021.
PMID: 33916610
Free PMC article.
Item in Clipboard
Cite
Cite